BofA analyst Joshua Dennerlein raised the firm’s price target on Equifax (EFX) to $300 from $280 and keeps a Buy rating on the shares. The firm walked away from Q1 results and calls with management with the view that Equifax’s business model has become more resilient than in years past. The firm cites an increased conviction level and higher estimates for its raised price target
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EFX:
- Equifax’s Resilience and Growth Potential: A Buy Recommendation by Joshua Dennerlein
- Equifax Surpasses Q1 Expectations Amid Market Challenges
- Equifax price target raised to $277 from $250 at Oppenheimer
- Equifax: Strong Financial Performance and Strategic Initiatives Drive Buy Rating
- Equifax Reports Strong Q1 2025 Results and New Initiatives
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue